N-Fmoc-N-methyl-(S)-2-allylglycine introduces N-methylation and an allyl substituent that reduce backbone flexibility and enable bioorthogonal derivatization. Researchers employ it to design sterically constrained peptides and reactive handles. The residue influences helix formation and hydrophobic interactions. Its protection ensures compatibility with multistep synthesis.
CAT No: R2174
CAS No:2606012-88-6
Synonyms/Alias:N-Fmoc-N-methyl-(S)-2-allylglycine;2606012-88-6;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)pent-4-enoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}pent-4-enoic acid;SCHEMBL24633907;G87274;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]pent-4-enoic acid;
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More